Summary:
- The article discusses the clinical efficacy and physiological impact of GLP-1 receptor agonists (such as semaglutide and tirzepatide) in the treatment of chronic obesity.
- It examines the complex intersection of metabolic health, the biological mechanisms of appetite regulation, and the long-term implications of pharmacological weight management interventions.